ganfort
allergan pharmaceuticals ireland - bimatoprost, timolol - glaucoma, open-angle, ocular hypertension - ophthalmologicals, - reduction of intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.
vallergan forte
sanofi-aventis new zealand limited - alimemazine tartrate 0.6%{relative}; ; alimemazine tartrate 0.6%{relative} - syrup - 30 mg/5ml - active: alimemazine tartrate 0.6%{relative} excipient: ascorbic acid citric acid as monohydrate ethanol prunus armeniaca purified water sodium benzoate sodium citrate dihydrate sodium metabisulfite sodium sulfite sucrose active: alimemazine tartrate 0.6%{relative} excipient: ascorbic acid citric acid monohydrate ethanol prunus armeniaca purified water sodium benzoate sodium citrate dihydrate sodium metabisulfite sodium sulfite sucrose - · urticaria
vistabel 4 allergan units/0.1ml, powder for solution for injection
abbvie limited citywest business campus, dublin 24, ireland - powder for solution for injection - botulinum toxin type a 4 allergan units/0.1 millilitre - muscle relaxants
botox 100 allergan units powder for solution for injection
abbvie limited citywest business campus, dublin 24, ireland - powder for solution for injection - botulinum toxin type a 100 allergan units/0.1 millilitre - muscle relaxants
botox 50 allergan units powder for solution for injection
abbvie limited citywest business campus, dublin 24, ireland - powder for solution for injection - botulinum toxin type a 50 allergan units/0.1 millilitre - muscle relaxants
botox 200 allergan units powder for solution for injection
abbvie limited citywest business campus, dublin 24, ireland - powder for solution for injection - botulinum toxin type a 200 allergan units/0.1 millilitre - muscle relaxants
desallergan solution oral
vetprom ad - desloratadine - solution oral - 0.5mg/ml
lastacaft® (alcaftadine ophthalmic solution) 0.25%
allergan singapore pte. ltd. - alcaftadine - solution, sterile - 2.5 mg/ml - alcaftadine 2.5 mg/ml
acuvail™ (ketorolac tromethamine ophthalmic solution) 0.45%
allergan singapore pte. ltd. - ketorolac tromethamine - solution, sterile - 0.45% w/v - ketorolac tromethamine 0.45% w/v
norco- hydrocodone bitartrate and acetaminophen tablet
allergan, inc. - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - hydrocodone bitartrate 5 mg - norco is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use : because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve norco for use in patients for whom alternative treatment options (e.g., non-opioid analgesics): - have not been tolerated, or are not expected to be tolerated - have not provided adequate analgesia, or are not expected to provide adequate analgesia norco is contraindicated in patients with: - significant respiratory depression [see warnings ] - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings ] - known or suspected gastrointestinal obstruction, including paralytic ileus [see warnings ] - hypersensitivity to hydrocodone or acetaminophen (e.g., anaphylaxis) [see warnings , adverse reactions ] norco contains hydrocodone, a schedule ii controlled substance. norco co